2025 Latin America Automatic Nucleic Acid Extraction Instrument Market Revenue Opportunities Report
Description
The 2025 Latin America Automatic Nucleic Acid Extraction Instrument Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Automatic Nucleic Acid Extraction Instrument Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Automatic Nucleic Acid Extraction Instrument Market in Latin America include QIAGEN, Thermo Fisher Scientific, MGI Tech, and F. Hoffmann-La Roche Ltd. QIAGEN and Thermo Fisher Scientific, both U.S.-based, are major global players offering comprehensive automated extraction solutions that are widely adopted in clinical and research labs globally. MGI Tech, a Chinese firm, has recently expanded its presence in Latin America through partnerships with local genomic centers and distributors in Mexico, Chile, and Colombia, supplying automated sample preparation systems and sequencers to support regional growth in genomics. F. Hoffmann-La Roche Ltd (Switzerland/U.S.) also maintains a significant market presence in the region, leveraging its broad diagnostic portfolio.
These companies lead the region by integrating advanced technologies such as magnetic bead-based extraction and benchtop sequencing for efficient nucleic acid isolation. Their efforts focus on meeting rising demand driven by infectious disease diagnostics, research advancement, and high-throughput lab automation. MGI Tech, notably, emphasizes local partnerships to facilitate technology adoption and improve health outcomes in Latin America. QIAGEN and Thermo Fisher are recognized for large R&D investments and extensive product ranges, strengthening their competitive edge. Collectively, these companies support Latin America's expanding biotech and diagnostics infrastructure with state-of-the-art automated instruments.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Automatic Nucleic Acid Extraction Instrument Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Automatic Nucleic Acid Extraction Instrument Market in Latin America include QIAGEN, Thermo Fisher Scientific, MGI Tech, and F. Hoffmann-La Roche Ltd. QIAGEN and Thermo Fisher Scientific, both U.S.-based, are major global players offering comprehensive automated extraction solutions that are widely adopted in clinical and research labs globally. MGI Tech, a Chinese firm, has recently expanded its presence in Latin America through partnerships with local genomic centers and distributors in Mexico, Chile, and Colombia, supplying automated sample preparation systems and sequencers to support regional growth in genomics. F. Hoffmann-La Roche Ltd (Switzerland/U.S.) also maintains a significant market presence in the region, leveraging its broad diagnostic portfolio.
These companies lead the region by integrating advanced technologies such as magnetic bead-based extraction and benchtop sequencing for efficient nucleic acid isolation. Their efforts focus on meeting rising demand driven by infectious disease diagnostics, research advancement, and high-throughput lab automation. MGI Tech, notably, emphasizes local partnerships to facilitate technology adoption and improve health outcomes in Latin America. QIAGEN and Thermo Fisher are recognized for large R&D investments and extensive product ranges, strengthening their competitive edge. Collectively, these companies support Latin America's expanding biotech and diagnostics infrastructure with state-of-the-art automated instruments.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
